Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Understanding the Complexities of The Tepezza Multi-District Litigation Lawsuit

As the legal industry constantly evolves, it encounters multifaceted cases involving innovative technologies or, as frequently, novel medical treatments. A salient example of this is the ongoing multi-district litigation (MDL) concerning Tepezza (teprotumumab-trbw) – a groundbreaking medication developed by Horizon Therapeutics for the treatment of Thyroid Eye Disease. [1]

Horizon Therapeutics came under legal fire for its choice to suspend Tepezza distribution to new patients. The company attributed the decision to Operation Warp Speed (the U.S. Federal Government’s COVID-19 vaccine manufacturing and distribution endeavor), which had prioritized the manufacturing of COVID-19 vaccines in Pfizer’s manufacturing facility. The facility was a crucial part of the Tepezza production line. [2]

However, the fallout from this decision has been the subject of several lawsuits, leading to complex, multi-district litigation that bears exploration.

Understanding Multi-District Litigation 

Before delving into the intricacies of the Tepezza litigation, it’s crucial to understand what makes multi-district litigation (MDL) distinct. Essentially, MDL is a process that consolidates multiple civil cases from different districts into one court. Judge Matthew Kennelly ruled on this centralized litigation concerning Tepezza in the Northern District of Illinois. [3]

The Root of the Lawsuit

The parties suing Horizon Therapeutics argue that the company misled investors regarding Tepezza. They claim Horizon failed to disclose that it would, in fact, be able to continue producing Tepezza despite Pfizer repurposing its facility for COVID vaccine manufacture. They argue Horizon misrepresented the situation to manipulate its stock prices. [3]:

The Lawsuit’s Implications

The future implications of this lawsuit depend on its outcome. If it goes in favor of the plaintiffs, it could set a precedent for other pharmaceutical companies about the level of transparency required when disclosing information that can affect stock prices. Moreover, it would pave an avenue for compensation to those affected.

If Horizon wins, it may send a message that these companies have considerable discretion in decision-making and communication. However, such an outcome could also lead to public and legal pressure for more stringent regulations on pharmaceutical industry disclosures.

Conclusion 

The case of the Tepezza MDL illustrates the complexity that can arise when the medical and legal fields intersect, particularly in an era impacted by a global pandemic. This case underscores the importance of proper investment information disclosure by pharmaceutical companies and the potential legal repercussions when this standard is not met. 

If you or a loved one has been injured by Tepezza, give us a call at the Michael Brady Lynch Firm at 888-585-5970. 

Date: June 30, 2023

Author: Brandon Salter and Anoop Desai

Citations

[1] https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-thyroid-eye-disease

[2] https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-announces-fda-approval-update#:~:text=14%2C%202023%2D%2D%20Horizon%20Therapeutics,Eye%20Disease%20activity%20or%20duration.%E2%80%9D

[3] https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3079-Transfer_Order-5-23.pdf

Mass Tort Litigation Updates: September 2024

Mass Tort Litigation Updates: September 2024

When you’ve suffered an injury or illness due to a defective drug, our drug injury attorneys at Michael Brady Lynch Firm hold big pharmaceutical companies responsible for their negligent behavior and failure to warn consumers about dangerous products. In the past few months, there have been significant updates to several of the most prominent mass tort cases currently in litigation.

read more
We Are Accepting Depo-Provera Lawsuits

We Are Accepting Depo-Provera Lawsuits

Depo-Provera, a contraceptive injection widely used by women to prevent pregnancy, has been the subject of numerous lawsuits in recent years. Manufactured by Pfizer, Depo-Provera contains the hormone progestin, which prevents ovulation and alters the uterine lining.

read more
PFAS Lawsuit Update: PFAS And Florida Water Contamination

PFAS Lawsuit Update: PFAS And Florida Water Contamination

Per-and Polyfluorinated Substances (commonly referred to as PFAS) are synthetic chemicals used in various household items, such as textiles, food packaging, and non-stick cookware. PFAS chemicals are also heavily found in fire extinguishing compounds, such as firefighter foams.

read more
We’re Taking Ozempic Blindness Cases!

We’re Taking Ozempic Blindness Cases!

Recently, there’s been some concern about a potential link between Ozempic, a common type 2 diabetes medication, and Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), also referred to as an eye stroke. NAION is a relatively rare condition in which a loss of blood flow and oxygen delivery to the optic nerve cause sudden and painless vision loss in one eye. This occurs when blood flow to the retina is blocked, which can suddenly aGect your vision. While Ozempic is eGective at managing blood sugar, it’s important to be aware of any potential side eGects, especially those involving your vision.

read more
We Take AFFF Cases

We Take AFFF Cases

Firefighting Foam Aqueous Film-Forming Foam (AFFF) is a commonly used fire suppressant in military and civilian applications. It effectively extinguishes fuel fires but contains per- and polyfluoroalkyl substances (PFAS), which are under legal scrutiny due to their environmental and health effects.

read more
×
What Our Clients Are Saying